QTREX Quantum Ltd.

QTEX ·Healthcare, Medical Devices
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $-13.2M $-11.1M $-11.3M $-15.0M $-17.2M $16.9M $-4.6M
Depreciation & Amortization — — — — — — —
Depreciation $150.0K $171.0K $111.0K $54.0K $25.0K $7.0K —
Amortization — — — — $107.0K $694.0K —
Stock-Based Compensation $3.6M $1.9M $1.4M $4.9M $6.7M — —
Net Cash from Operating Activities $-9.9M $-9.4M $-9.7M $-9.2M $-6.7M $-1.9M $-1.1M
Investing Activities
Capital Expenditures $103.0K $164.0K $206.0K $263.0K $182.0K $23.0K $31.0K
Business Acquisitions — — $16.0M — — — —
Net Cash from Investing Activities $565.0K $1.5M $4.6M $-7.4M $-182.0K $-26.0K $-71.0K
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $7.3M $7.9M $3.5M $-399.0K $30.2M $2.3M $1.3M
Net Change in Cash — — — $-15.0M $22.3M $387.0K $85.0K
Free Cash Flow $-10.0M $-9.5M $-9.9M $-9.5M $-6.9M $-1.9M $-1.1M